DRUG · Mapped RxNorm record
aripiprazole
Normalized identity: aripiprazole View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders
NCT00036127
Study summary
ClinicalTrials.govStudy of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2, PHASE3
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Advertisement
Conditions
Schizophreniaverified · MONDO: schizophrenia
Interventions
aripiprazoleDRUG · verified · RxNorm: aripiprazole
Sponsors & collaborators
Mapped research locations
New YorkNew York, United States1HoustonTexas, United States1PhiladelphiaPennsylvania, United States1AtlantaGeorgia, United States1San DiegoCalifornia, United States1Las VegasNevada, United States1CharlestonSouth Carolina, United States1MilwaukeeWisconsin, United States1AnaheimCalifornia, United States1Chula VistaCalifornia, United States1MaconGeorgia, United States1BeachwoodOhio, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00036127 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.